TSPO and glioblastoma: First experimental glioblastoma investigations with murine GL261 in immunocompetent mice (9), human P3 in immunodeficient mice (10), and human U87 in immunodeficient rats (11) indicated feasibility of TSPO PET monitoring by different radiotracers.